Profile
Factory Capital is a globally focused investment firm with over 15 years of experience, headquartered in Sydney, New South Wales, Australia. The firm is led by a team of seasoned professionals with backgrounds in deal-making, executive management, and business turnarounds. Factory Capital distinguishes itself by creating proprietary investment opportunities and accelerating founder-led businesses through its Principal Investment arm and Fund Management platforms, HEAL Partners and RealVC.
The firm invests across a range of sectors, including venture funds, growth private equity, and private credit. Factory Capital operates in North America, Europe, and the Asia-Pacific region. The firm manages several funds, including the Capital Factory Fund and the Factory Capital Women's Midlife Health Initiative, with a focus on delivering strong cash-on-cash returns and founder-style equity.
Factory Capital has a track record of driving growth and reducing risk in its portfolio companies. The firm partners with founders and businesses to enhance executive management capabilities and transform them into investment-grade businesses. Notable investments include companies that have achieved significant growth and attracted institutional buyers.
Industry
Factory Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Capital Factory Fund
|
Venture Capital (VC)
|
Healthcare Services
Marketing and Advertising
SaaS
Security
Software
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$3 M
|
August 2009
|
|
Factory Capital Women's Midlife Health Initiative
|
Venture Capital (VC)
|
Healthcare Services
Life Sciences
HealthTech
|
Seed
Series A
|
North America
|
$1-5 m
|
$25 M
|
May 2026
|
|
Factory Capital Fund
|
Venture Capital (VC)
|
Aerospace
Biotechnology
Energy
Defense
|
Seed
|
North America
|
$1-5 m
|
$18 M
|
June 2026
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.